Low-FODMAP Diet in the Treatment of Irritable Bowel Syndrome – Efficacy, Comparison with Other Diets, Mechanisms, and Clinical Applications

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that significantly impacts patients' quality of life. One of the most frequently used and well-documented dietary approaches in the treatment of IBS is the low-FODMAP diet, which involves the elimination of ferment...

Full description

Saved in:
Bibliographic Details
Main Authors: Konrad Strużek, Kornelia Karamus, Rafał Rejmak, Jan Biłogras, Martyna Borowska-Łygan, Wojciech Urban, Jakub Tomaszewski
Format: Article
Language:English
Published: Kazimierz Wielki University 2025-04-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/59059
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761050241531904
author Konrad Strużek
Kornelia Karamus
Rafał Rejmak
Jan Biłogras
Martyna Borowska-Łygan
Wojciech Urban
Jakub Tomaszewski
author_facet Konrad Strużek
Kornelia Karamus
Rafał Rejmak
Jan Biłogras
Martyna Borowska-Łygan
Wojciech Urban
Jakub Tomaszewski
author_sort Konrad Strużek
collection DOAJ
description Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that significantly impacts patients' quality of life. One of the most frequently used and well-documented dietary approaches in the treatment of IBS is the low-FODMAP diet, which involves the elimination of fermentable oligosaccharides, disaccharides, monosaccharides, and polyols that can exacerbate gastrointestinal symptoms.   This article presents the mechanisms of action of the FODMAP diet, its effectiveness, and a comparison with other dietary approaches used in IBS, such as the gluten-free and Mediterranean diets. The three-phase model of the diet, including the elimination, reintroduction, and personalization phases, is discussed, enabling dietary adaptation to individual patient tolerance. A review of studies has shown that the effectiveness of the FODMAP diet in reducing IBS symptoms ranges from 50% to 75%, making it one of the most effective dietary strategies for managing this condition.   Additionally, potential biomarkers for dietary response, such as breath tests, gut microbiota analysis, and fecal and urinary metabolites, are explored to help identify patients who may benefit most from this approach. The article also emphasizes the importance of a multidisciplinary approach in IBS treatment, integrating dietary therapy, gastroenterological support, and psychological interventions.   Despite the high efficacy of the FODMAP diet, its long-term consequences, particularly its impact on gut microbiota and metabolism, require further research. The article highlights the need for continued analysis of the diet’s lasting effects and its effectiveness in different IBS subtypes, which could contribute to even better personalization of therapeutic strategies to meet patients' individual needs.  
format Article
id doaj-art-9a02c09b95b0474a9cbce376c75a65d3
institution DOAJ
issn 2391-8306
language English
publishDate 2025-04-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj-art-9a02c09b95b0474a9cbce376c75a65d32025-08-20T03:06:09ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062025-04-018010.12775/JEHS.2025.80.59059Low-FODMAP Diet in the Treatment of Irritable Bowel Syndrome – Efficacy, Comparison with Other Diets, Mechanisms, and Clinical ApplicationsKonrad Strużekhttps://orcid.org/0009-0000-3146-5132Kornelia Karamus0https://orcid.org/0000-0001-7453-1427Rafał Rejmak1https://orcid.org/0009-0002-9422-8550Jan Biłogras2https://orcid.org/0009-0002-6038-9217Martyna Borowska-Łygan3https://orcid.org/0009-0001-9402-7444Wojciech Urban4https://orcid.org/0009-0009-1565-0595Jakub Tomaszewski5https://orcid.org/0009-0009-9384-4643UniwersyteckiSzpitalKlinicznynr4wLublinieUniwersytecki Szpital Kliniczny nr 4 w Lublinie1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w LublinieMazowiecki Szpital Specjalistyczny w RadomiuWojewódzki szpital specjalistyczny im Stefana Kardynała Wyszyńskiego SPZOZ w LublinieUniwersytecki Szpital Kliniczny nr 4 w Lublinie Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that significantly impacts patients' quality of life. One of the most frequently used and well-documented dietary approaches in the treatment of IBS is the low-FODMAP diet, which involves the elimination of fermentable oligosaccharides, disaccharides, monosaccharides, and polyols that can exacerbate gastrointestinal symptoms.   This article presents the mechanisms of action of the FODMAP diet, its effectiveness, and a comparison with other dietary approaches used in IBS, such as the gluten-free and Mediterranean diets. The three-phase model of the diet, including the elimination, reintroduction, and personalization phases, is discussed, enabling dietary adaptation to individual patient tolerance. A review of studies has shown that the effectiveness of the FODMAP diet in reducing IBS symptoms ranges from 50% to 75%, making it one of the most effective dietary strategies for managing this condition.   Additionally, potential biomarkers for dietary response, such as breath tests, gut microbiota analysis, and fecal and urinary metabolites, are explored to help identify patients who may benefit most from this approach. The article also emphasizes the importance of a multidisciplinary approach in IBS treatment, integrating dietary therapy, gastroenterological support, and psychological interventions.   Despite the high efficacy of the FODMAP diet, its long-term consequences, particularly its impact on gut microbiota and metabolism, require further research. The article highlights the need for continued analysis of the diet’s lasting effects and its effectiveness in different IBS subtypes, which could contribute to even better personalization of therapeutic strategies to meet patients' individual needs.   https://apcz.umk.pl/JEHS/article/view/59059Irritable bowel syndrome (IBS)low-FODMAP dietfermentable oligosaccharidesdisaccharides, monosaccharidesand polyols (FODMAP)dietary treatment of IBS
spellingShingle Konrad Strużek
Kornelia Karamus
Rafał Rejmak
Jan Biłogras
Martyna Borowska-Łygan
Wojciech Urban
Jakub Tomaszewski
Low-FODMAP Diet in the Treatment of Irritable Bowel Syndrome – Efficacy, Comparison with Other Diets, Mechanisms, and Clinical Applications
Journal of Education, Health and Sport
Irritable bowel syndrome (IBS)
low-FODMAP diet
fermentable oligosaccharides
disaccharides, monosaccharides
and polyols (FODMAP)
dietary treatment of IBS
title Low-FODMAP Diet in the Treatment of Irritable Bowel Syndrome – Efficacy, Comparison with Other Diets, Mechanisms, and Clinical Applications
title_full Low-FODMAP Diet in the Treatment of Irritable Bowel Syndrome – Efficacy, Comparison with Other Diets, Mechanisms, and Clinical Applications
title_fullStr Low-FODMAP Diet in the Treatment of Irritable Bowel Syndrome – Efficacy, Comparison with Other Diets, Mechanisms, and Clinical Applications
title_full_unstemmed Low-FODMAP Diet in the Treatment of Irritable Bowel Syndrome – Efficacy, Comparison with Other Diets, Mechanisms, and Clinical Applications
title_short Low-FODMAP Diet in the Treatment of Irritable Bowel Syndrome – Efficacy, Comparison with Other Diets, Mechanisms, and Clinical Applications
title_sort low fodmap diet in the treatment of irritable bowel syndrome efficacy comparison with other diets mechanisms and clinical applications
topic Irritable bowel syndrome (IBS)
low-FODMAP diet
fermentable oligosaccharides
disaccharides, monosaccharides
and polyols (FODMAP)
dietary treatment of IBS
url https://apcz.umk.pl/JEHS/article/view/59059
work_keys_str_mv AT konradstruzek lowfodmapdietinthetreatmentofirritablebowelsyndromeefficacycomparisonwithotherdietsmechanismsandclinicalapplications
AT korneliakaramus lowfodmapdietinthetreatmentofirritablebowelsyndromeefficacycomparisonwithotherdietsmechanismsandclinicalapplications
AT rafałrejmak lowfodmapdietinthetreatmentofirritablebowelsyndromeefficacycomparisonwithotherdietsmechanismsandclinicalapplications
AT janbiłogras lowfodmapdietinthetreatmentofirritablebowelsyndromeefficacycomparisonwithotherdietsmechanismsandclinicalapplications
AT martynaborowskałygan lowfodmapdietinthetreatmentofirritablebowelsyndromeefficacycomparisonwithotherdietsmechanismsandclinicalapplications
AT wojciechurban lowfodmapdietinthetreatmentofirritablebowelsyndromeefficacycomparisonwithotherdietsmechanismsandclinicalapplications
AT jakubtomaszewski lowfodmapdietinthetreatmentofirritablebowelsyndromeefficacycomparisonwithotherdietsmechanismsandclinicalapplications